Evaluation of Cardiotoxic Effects of Bortezomib
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE3
Bortezomib Maintenance in High Risk DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Proteasome Inhibition in Acute Promyelocytic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib to Treat Significant Complication of HSCT
- Status
- COMPLETED
- Phase
- PHASE2
Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Maintenance Therapy With Subcutaneous Bortezomib
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Tolerability Study of Bortezomib in Combination With Rituximab Standard Therapy in Participants With Relapsed or Refractory Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Late Antibody-mediated Kidney Transplant Rejection
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin
- Status
- TERMINATED
- Phase
- PHASE1
Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI.
- Status
- COMPLETED
- Phase
- PHASE2
Desensitization With Bortezomib Before a Living Kidney Donation
- Status
- UNKNOWN
- Phase
- PHASE4
Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D
- Status
- COMPLETED
- Phase
- PHASE2